Multisource Surveillance Study of Pregnancy and Infant Outcomes in Ocrelizumab-Exposed Women With Multiple Sclerosis (MELODIC Study)

28/02/2020
02/07/2024
EU PAS number:
EUPAS33879
Study
Planned

ENCePP Code of conduct

No
Data sources

Data source(s)

Data source(s), other

Danish Registries (access/analysis), DAPI database

Data sources (types)

Administrative healthcare records (e.g., claims)
Disease registry
Drug dispensing/prescription data
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No